OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Via Christi is the first hospital in the region to perform a new procedure for atrial fibrillation for patients who can’t ...

PRNewswire New York [US] 13 Fourth Frontier a medical technology company based out of New York and Bangalore announced the ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11%, a study shows.

New innovation harnesses the power of artificial intelligence in a wearable IoT device for real-time heart monitoring ... and ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

Professor Allan Lawrie discusses the future of personalised cardiovascular disease detection and monitoring and wearable ...

New research finds that on extremely hot days, people with implanted defibrillators face nearly triple the odds for a ...